. Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol 291: L1159 -L1168, 2006. First published August 4, 2006 doi:10.1152/ajplung.00168.2006-From a mouse model of hypoxiainduced pulmonary hypertension, we previously found a highly upregulated protein in the lung that we named hypoxia-induced mitogenic factor (HIMF), also known as found in inflammatory zone 1 (FIZZ1), and resistin-like molecule ␣ (RELM␣). However, the mechanisms of HIMF in the pulmonary vascular remodeling remain unknown. We now demonstrate that HIMF promoted cell proliferation, migration, and the production of vascular endothelial growth factor (VEGF) and monocyte chemotactic protein-1 (MCP-1) in pulmonary endothelial cells as well as the production of reactive oxygen species in murine monocyte/macrophage cells. HIMF-induced CD31-positive cell infiltrate in in vivo Matrigel plugs was significantly suppressed by VEGF receptor-2 (VEGFR2) blockade. In ex vivo studies, HIMF stimulated the production of VEGF, MCP-1, and stromal cell-derived factor-1 (SDF-1) in the lung resident cells, and VEGFR2 neutralization significantly suppressed HIMF-induced MCP-1 and SDF-1 production. Furthermore, intravenous injection of HIMF showed marked increase of CD68-positive inflammatory cells in the lungs, and these events were attenuated by VEGFR2 neutralization. Intravenous injection of HIMF also downregulated the expression of VEGFR2 in the lung. These results suggest that HIMF plays critical roles in pulmonary inflammation as well as angiogenesis. vascular endothelial growth factor; monocyte chemotactic protein-1; vascular endothelial growth factor receptor-2; pulmonary inflammation; hypoxia-induced mitogenic factor; found in inflammatory zone 1; resistin-like molecule ␣ PULMONARY HYPERTENSION (PH) is a serious disease of poorly understood etiology characterized by raised pulmonary artery pressure, leading to progressive right-sided heart failure and ultimately death (32). PH results from intimal thickening of small pulmonary resistance arteries that results, at least in part, from endothelial and smooth muscle cell dysfunction and proliferation (41). Increased vascular endothelial cell (EC) proliferation and muscularization of the vasculature are the pathological characteristics of pulmonary vascular remodeling, and it has been demonstrated that this process is associated with hypoxia-induced production of angiogenic factors, inflammatory mediators, and vasoconstrictors.From a mouse model of hypoxia-induced PH, we previously found a highly upregulated protein that we named hypoxiainduced mitogenic factor (HIMF) (37). A microarray study showed that HIMF gene was significantly upregulated in the lungs of mice that were exposed to hypoxia for 1-4 days. We demonstrated that the recombinant protein of this gene has mitogenic actions and stimulated pulmonary microvascular smooth muscle cell proliferation via an Akt-dependent pathway.